Charles Schwab Investment Management Inc C4 Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $521 Billion
  • Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 474,843 shares of CCCC stock, worth $674,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares
474,843
Previous 486,366 2.37%
Holding current value
$674,277
Previous $1.75 Million 56.63%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$1.6 - $4.09 $18,436 - $47,129
-11,523 Reduced 2.37%
474,843 $759,000
Q4 2024

Feb 06, 2025
BUY
$3.6 - $7.0 $12,373 - $24,059
3,437 Added 0.71%
486,366 $1.75 Million
Q3 2024

Nov 12, 2024
SELL
$4.43 - $7.38 $26,708 - $44,494
-6,029 Reduced 1.23%
482,929 $2.75 Million
Q2 2024

Aug 12, 2024
BUY
$4.05 - $8.1 $897,192 - $1.79 Million
221,529 Added 82.84%
488,958 $2.26 Million
Q1 2024

May 08, 2024
BUY
$5.3 - $11.0 $78,010 - $161,909
14,719 Added 5.82%
267,429 $2.18 Million
Q4 2023

Feb 06, 2024
BUY
$1.18 - $6.03 $5,260 - $26,881
4,458 Added 1.8%
252,710 $1.43 Million
Q3 2023

Nov 08, 2023
BUY
$1.81 - $3.89 $31,164 - $66,978
17,218 Added 7.45%
248,252 $461,000
Q2 2023

Aug 09, 2023
SELL
$2.75 - $3.77 $236,431 - $324,125
-85,975 Reduced 27.12%
231,034 $635,000
Q1 2023

May 11, 2023
SELL
$3.1 - $9.02 $122,893 - $357,579
-39,643 Reduced 11.12%
317,009 $995,000
Q4 2022

Feb 13, 2023
BUY
$5.42 - $10.24 $24,536 - $46,356
4,527 Added 1.29%
356,652 $2.1 Million
Q3 2022

Nov 14, 2022
BUY
$8.03 - $12.77 $633,856 - $1.01 Million
78,936 Added 28.89%
352,125 $3.09 Million
Q2 2022

Aug 15, 2022
BUY
$5.06 - $26.46 $263 - $1,375
52 Added 0.02%
273,189 $2.06 Million
Q1 2022

May 13, 2022
BUY
$19.99 - $33.23 $169,635 - $281,989
8,486 Added 3.21%
273,137 $6.63 Million
Q4 2021

Feb 11, 2022
BUY
$29.39 - $46.86 $123,408 - $196,765
4,199 Added 1.61%
264,651 $8.52 Million
Q3 2021

Nov 16, 2021
BUY
$35.91 - $50.5 $4.3 Million - $6.05 Million
119,858 Added 85.25%
260,452 $11.6 Million
Q2 2021

Aug 16, 2021
BUY
$30.39 - $42.18 $2.15 Million - $2.99 Million
70,882 Added 101.68%
140,594 $5.32 Million
Q1 2021

May 17, 2021
BUY
$31.96 - $46.5 $94,921 - $138,105
2,970 Added 4.45%
69,712 $2.58 Million
Q4 2020

Feb 16, 2021
BUY
$22.8 - $37.05 $1.52 Million - $2.47 Million
66,742 New
66,742 $2.21 Million

Others Institutions Holding CCCC

# of Institutions
118
Shares Held
63.1M
Call Options Held
18.8K
Put Options Held
0
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $69.5M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email